Evaluation of the Relationship Between Procalcitonin Level and the Causative Pathogen in Intensive Care Patients With Sepsis

References

• Singer M , DeutschmanCS , SeymourCWet al. The third international consensus definitions for sepsis and septic shock (SEPSIS-3). JAMA315(8), 801–810 (2016).
   PubMed Web of Science ®Google Scholar
• Nasa P , JunejaD , SinghO , DangR , AroraV. Severe sepsis and its impact on outcome in elderly and very elderly patients admitted in intensive care unit. J. Intensive Care Med.27(3), 179–183 (2012).
   PubMedGoogle Scholar
• Chen CM , ChengKC , ChanKS , YuWL. Age may not influence the outcome of patients with severe sepsis in intensive care units. Int. J. Gerontol.8, 22–26 (2014).
   Web of Science ®Google Scholar
• Vincent J-L , MarshallJC , Ñamendys-SilvaSAet al. Assessment of the worldwide burden of critical illness: the intensive care over nations (ICON) audit. Lancet Respir. Med.2, 380–386 (2014).
   PubMed Web of Science ®Google Scholar
• Jarczak D , KlugeS , NierhausA. Sepsis-pathophysiology and therapeutic concepts. Front. Med. (Lausanne)8, 628302 (2021).
   PubMed Web of Science ®Google Scholar
• Li S , RongH , GuoQ , ChenY , ZhangG , YangJ. Serum procalcitonin levels distinguish Gram-negative bacterial sepsis from Gram-positive bacterial and fungal sepsis. J. Res. Med. Sci.21, 39 (2016).
   PubMed Web of Science ®Google Scholar
• Gullo A , BiancoN , BerlotG. Management of severe sepsis and septic shock: challenges and recommendations. Crit. Care Clin.22(3), 489–501 (2006).
   PubMed Web of Science ®Google Scholar
• Marshall JC , ReinhartK. Biomarkers of sepsis. Crit. Care Med.37(7), 2290–2298 (2009).
   PubMed Web of Science ®Google Scholar
• Langley RJ , TsalikEL , van VelkinburghJCet al. An integrated clinico-metabolomic model improves prediction of death in sepsis. Sci. Transl. Med.5(195), 195ra95 (2013).
   PubMed Web of Science ®Google Scholar
• Leli C , FerrantiM , MorettiA , AlDhahab ZS , CenciE , MencacciA. Procalcitonin levels in Gram-positive, Gram-negative, and fungal bloodstream infections. Dis. Markers2015, 701480 (2015).
   PubMed Web of Science ®Google Scholar
• Brodska H , MalickovaK , AdamkovaV , BenakovaH , StastnaMM , ZimaT. Significantly higher procalcitonin levels could differentiate Gram-negative sepsis from Gram-positive and fungal sepsis. Clin. Exp. Med.13, 165–170 (2013).
   PubMed Web of Science ®Google Scholar
• Guo SY , ZhouY , HuQF , YaoJ , WangH. Procalcitonin is a marker of Gram-negative bacteremia in patients with sepsis. Am. J. Med. Sci.349, 499–504 (2015).
   PubMed Web of Science ®Google Scholar
• Baykara N , AkalınH , ArslantaşMKet al. Epidemiology of sepsis in intensive care units in turkey: a multicenter, point-prevalence study. Crit. Care22(1), 93 (2018).
   PubMedGoogle Scholar
• Markus B , PeterAW. The inflammatory response in sepsis. Trends Immunol.34, 129–136 (2013).
   PubMed Web of Science ®Google Scholar
• Bassetti M , RighiE , CarneluttiA. Bloodstream infections in the intensive care unit. Virulence7, 267–279 (2016).
   PubMed Web of Science ®Google Scholar
• Bilgili B , HaliloğluM , AslanMS , Sayanİ , KasapoğluUS , Cinelİ. Diagnostic accuracy of procalcitonin for differentiating bacteraemic Gram-Negative sepsis from Gram-Positive sepsis. Turk. J. Anaesthesiol. Reanim.46(1), 38–43 (2018).
   PubMedGoogle Scholar
• Cabral L , AfreixoV , MeirelesRet al. Evaluation of procalcitonin accuracy for the distinction between Gram-negative and Gram-positive bacterial sepsis in burn patients. J. Burn Care Res.40(1), 112–119 (2019).
   PubMed Web of Science ®Google Scholar
• Mayr FB , YendeS , AngusDC. Epidemiology of severe sepsis. Virulence5(1), 4–11 (2014).
   PubMed Web of Science ®Google Scholar
• Cernada M , Pinilla-GonzálezA , KuligowskiJet al. Transcriptome profiles discriminate between Gram-positive and Gram-negative sepsis in preterm neonates. Pediatr. Res.91(3), 637–645 (2022).
   PubMed Web of Science ®Google Scholar
• Niederman MS , BaronRM , BouadmaLet al. Initial antimicrobial management of sepsis. Crit. Care.25(1), 307 (2021).
   PubMed Web of Science ®Google Scholar
• Gao Y , LinH , XuYet al. Prognostic risk factors of carbapenem-resistant Gram-negative bacteria bloodstream infection in immunosuppressed patients: a 7-year retrospective cohort study. Infect. Drug Resist.15, 6451–6462 (2022).
   PubMed Web of Science ®Google Scholar
• Schuetz P , AffolterB , HunzikerSet al. Serum procalcitonin, C-reactive protein and white blood cell levels following hypothermia after cardiac arrest: a retrospective cohort study. Eur. J. Clin. Invest.40, 376–381 (2010).
   PubMed Web of Science ®Google Scholar
• Ryoo SM , HanKS , AhnSet al. The usefulness of C-reactive protein and procalcitonin to predict prognosis in septic shock patients: a multicenter prospective registry-based observational study. Sci. Rep.9(1), 6579 (2019).
   PubMedGoogle Scholar
• Castelli GP , PognaniC , CitaM , StuaniA , SgarbiL , PaladiniR. Procalcitonin, C-reactive protein, white blood cells and SOFA score in ICU: diagnosis and monitoring of sepsis. Minerva Anestesiol.72(1–2), 69–80 (2006).
   PubMed Web of Science ®Google Scholar
• Pradhan S , GhimireA , BhattaraiBet al. The role of C-reactive protein as a diagnostic predictor of sepsis in a multidisciplinary intensive care unit of a tertiary care center in Nepal. Indian J. Crit. Care Med.20(7), 417–420 (2016).
   PubMedGoogle Scholar
• Vijayan AL , Vanimaya , RavindranSet al. Procalcitonin: a promising diagnostic marker for sepsis and antibiotic therapy. J. Intensive Care5, 51 (2017).
   PubMed Web of Science ®Google Scholar
• Arora S , SinghP , SinghPM , TrikhaA. Procalcitonin levels in survivors and nonsurvivors of sepsis: systematic review and meta-analysis. Shock43, 212–221 (2015).
   PubMed Web of Science ®Google Scholar
• Schuetz P , BirkhahnR , SherwinRet al. Serial procalcitonin predicts mortality in severe sepsis patients: results from the multicenter procalcitonin MOnitoring SEpsis (MOSES) study. Crit. Care Med.45(5), 781 (2017).
   PubMed Web of Science ®Google Scholar
• Varis E , PettiläV , PoukkanenMet al. Evolution of blood lactate and 90-day mortality in septic shock. a post hoc analysis of the FINNAKI study. Shock47(5), 574–581 (2017).
   PubMed Web of Science ®Google Scholar
• Safari S , ShojaeeM , RahmatiFet al. Accuracy of SOFA score in prediction of 30-day outcome of critically ill patients. Turk. J. Emerg. Med.16, 146–150 (2016).
   PubMedGoogle Scholar
• Chen YX , WangJY , GuoSB. Use of CRB-65 and quick sepsis-related organ failure assessment to predict site of care and mortality in pneumonia patients in the emergency department: a retrospective study. Crit. Care20, 167 (2016).
   PubMed Web of Science ®Google Scholar
• Djordjevic D , RondovicG , SurbatovicMet al. Neutrophil-to-lymphocyte ratio, monocyte-to-lymphocyte ratio, platelet-to-lymphocyte ratio, and mean platelet volume-to-platelet count ratio as biomarkers in critically ill and injure patients: which ratio to choose to predict outcome and nature of bacteremia? Mediators Inflamm. 2018, 3758068 (2018).
   PubMed Web of Science ®Google Scholar
• Riche F , GayatE , BarthelemyR , LeDorze M , MateoJ , PayenD. Reversal of neutrophil-to-lymphocyte count ratio in early versus late death from septic shock. Crit. Care19, 439 (2015).
   PubMed Web of Science ®Google Scholar
• Salciccioli JD , MarshallDC , PimentelMAet al. The association between the neutrophil-to-lymphocyte ratio and mortality in critical illness: an observational cohort study. Crit. Care19(1), 1–8 (2015).
   PubMedGoogle Scholar
• Lai L , LaiY , WangHet al. Diagnostic accuracy of procalcitonin compared to C-reactive protein and interleukin 6 in recognizing gram-negative bloodstream infection: a meta-analytic study. Dis. Markers2020, 4873074 (2020).
   PubMed Web of Science ®Google Scholar